Nom du produit:5-(3-methoxybenzyl)-7-(trifluoromethyl)-1,2,3,3a-tetrahydropyrrolo[1,2-a]quinoxalin-4(5H)-one
IUPAC Name:5-[(3-methoxyphenyl)methyl]-7-(trifluoromethyl)-1H,2H,3H,3aH,4H,5H-pyrrolo[1,2-a]quinoxalin-4-one
- CAS:1008035-84-4
- Formule moléculaire:C20H19F3N2O2
- Pureté:95%+
- Numéro de catalogue:CM1047569
- Poids moléculaire:376.38
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1008035-84-4
- Formule moléculaire:C20H19F3N2O2
- Point de fusion:-
- Code SMILES:O=C1C(CCC2)N2C3=C(C=C(C(F)(F)F)C=C3)N1CC4=CC=CC(OC)=C4
- Densité:
- Numéro de catalogue:CM1047569
- Poids moléculaire:376.38
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.